Norwest Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 1984.
1984 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Norwest Pharmaceuticals Private Limited

Norwest Pharmaceuticals Private Limited, a active private limited company, was established on 28 April 1984 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1984PTC018048. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.20 M and a paid-up capital of ₹1.12 M.

It upholds a compliant status. Its leadership includes Sandhya Sawhney (Director), Nitin Sawhney (Director). Past directors included Babal Suri, Suresh Kumar Suri. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-99Mansarovar Garden, New Delhi, Delhi, 110015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1984PTC018048

  • Registration Number

    018048

  • Incorporation Date

    28 April 1984

  • Authorized Capital

    ₹1.20 M

  • Paid-Up Capital

    ₹1.12 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.20 M
  • Paid Up Capital ₹ 1.12 M
  • Company Age 41 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** -45.21%
  • Profit Growth **** 58.69%
  • Ebitda **** 1282.38%
  • Net Worth -46.76%
  • Total Assets -6.26%
Company report

Norwest Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Norwest Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Norwest Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sandhya Sawhney Director 16 Aug 2010 Current
Nitin Sawhney Director 30 Sep 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Oct 2022 Past
Pramod Abcsdd Director 16 Aug 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Norwest Pharmaceuticals.

Norwest Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 45.21% decrease. The company also saw a substantial improvement in profitability, with a 58.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 46.76%.

Norwest Pharmaceuticals revenue growth over time
Norwest Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -45.21%
*******
*******
*******
*******
Revenue from Operations
*******
 -45.21%
*******
*******
*******
*******
Total Assets
*******
 -6.26%
*******
*******
*******
*******
Profit or Loss
*******
 58.69%
*******
*******
*******
*******
Net Worth
*******
 -46.76%
*******
*******
*******
*******
EBITDA
*******
 1282.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Norwest Pharmaceuticals?

Unlock access to Norwest Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Norwest Pharmaceuticals?

Unlock and access historical data on people associated with Norwest Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Norwest Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norwest Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Norwest Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Norwest Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Norwest Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Nitin Sawhney was appointed as a Director was appointed as a Director on 30 Sep 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.

  • Director Appointment

    Sandhya Sawhney was appointed as a Director was appointed as a Director on 16 Aug 2010 & has been associated with this company since 15 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Norwest Pharmaceuticals Private Limited was registered on 28 Apr 1984 with Roc Delhi & aged 41 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Norwest Pharmaceuticals Private Limited?

The CIN of Norwest Pharmaceuticals Private Limited is U74899DL1984PTC018048.

Where is Norwest Pharmaceuticals Private Limited headquartered?

Norwest Pharmaceuticals Private Limited is headquartered at E-99Mansarovar Garden, New Delhi, Delhi, 110015.

When was Norwest Pharmaceuticals Private Limited incorporated?

Norwest Pharmaceuticals Private Limited was incorporated on 28 April 1984.

Who are the current directors of Norwest Pharmaceuticals Private Limited?

The current directors of Norwest Pharmaceuticals Private Limited are

What is the primary industry of Norwest Pharmaceuticals Private Limited?

The primary industry of Norwest Pharmaceuticals Private Limited is Manufacturing.

Is Norwest Pharmaceuticals Private Limited a listed company?

Norwest Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Norwest Pharmaceuticals Private Limited?

The authorized capital of Norwest Pharmaceuticals Private Limited is ₹1.20 M, and the paid-up capital is ₹1.12 M.

What is the compliance status of Norwest Pharmaceuticals Private Limited?

The compliance status of Norwest Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available